You just read:

Glenmark Pharmaceuticals Licenses Small Molecule Oncology Compound from APC Therapeutics to Expand Immuno-Oncology Portfolio

News provided by

Glenmark Pharmaceuticals

Jun 20, 2017, 08:00 ET